This topic contains a solution. Click here to go to the answer

Author Question: E-health practices _____. A) Are subject to the same requirements for safeguarding confidentiality ... (Read 92 times)

jparksx

  • Hero Member
  • *****
  • Posts: 570
E-health practices _____.
 A) Are subject to the same requirements for safeguarding confidentiality of PHI
  B) Have been assigned exempt status from HIPAA regulations and requirements
  C) Govern only those patients who receive Medicare reimbursable services
  D) May be implemented by entities subject to Medicare Conditions of Participation

Question 2

HIPAA Security Rules and Privacy Rules are similar, yet different, in that both _____.
 A) Are different names for the same regulations
  B) Limit patient access and control of information
  C) Often oppose each rule's efforts and results
  D) Protect information from different aspects



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

leahm14

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

A

Answer to Question 2

D




jparksx

  • Member
  • Posts: 570
Reply 2 on: Jul 12, 2018
:D TYSM


raili21

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The oldest recorded age was 122. Madame Jeanne Calment was born in France in 1875 and died in 1997. She was a vegetarian and loved olive oil, port wine, and chocolate.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Throughout history, plants containing cardiac steroids have been used as heart drugs and as poisons (e.g., in arrows used in combat), emetics, and diuretics.

Did you know?

In most cases, kidneys can recover from almost complete loss of function, such as in acute kidney (renal) failure.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library